We are live on
!
Find out more
UroGen Pharma
URGN
URGN
167 hedge funds and large institutions have $1.02B invested in UroGen Pharma in 2025 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 52 increasing their positions, 53 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
371% more call options, than puts
Call options by funds: $33.9M | Put options by funds: $7.2M
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
25% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 24
15% more capital invested
Capital invested by funds: $891M → $1.02B (+$132M)
4% more funds holding
Funds holding: 161 → 167 (+6)
2% less repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 53
1.67% less ownership
Funds ownership: 95.05% → 93.38% (-1.7%)
Holders
167
Holders Change
+6
Holders Change %
+3.73%
% of All Funds
2.03%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.05%
New
30
Increased
52
Reduced
53
Closed
24
Calls
$33.9M
Puts
$7.2M
Net Calls
+$26.7M
Net Calls Change
+$1.59M
Top Buyers
Top Sellers
| 1 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
-$63.7M |
| 2 |
Millennium Management
New York
|
-$18.4M |
| 3 |
TCM
Tang Capital Management
San Diego,
California
|
-$14.1M |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$11.5M |
| 5 |
JP Morgan Chase
New York
|
-$8.42M |
